Transient Asystole after Sugammadex Administration for Immediate Reversal of Deep Blockade while on Dexmedetomidine Infusion in a Super Obese Patient
Sugammadex is increasingly used to reverse aminosteroid neuromuscular blocking agents. Dosing is calculated based on actual body weight, even for those who are obese. We report a case where a super obese patient (BMI 58.5 kg/m2) developed asystole, following coadministration with dexmedetomidine, fo...
Saved in:
Main Authors: | Michal Gajewski, Sorochi Esochaghi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Anesthesiology |
Online Access: | http://dx.doi.org/10.1155/2019/2709568 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to “Bradycardia Leading to Asystole Following Dexmedetomidine Infusion during Cataract Surgery: Dexmedetomidine-Induced Asystole for Cataract Surgery”
by: Aikaterini Amaniti, et al.
Published: (2019-01-01) -
Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
by: Kazim Mirza, et al.
Published: (2020-01-01) -
Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
by: Manzo Suzuki, et al.
Published: (2014-01-01) -
Asystole after Orthotopic Lung Transplantation: Examining the Interaction of Cardiac Denervation and Dexmedetomidine
by: Christopher Allen-John Webb, et al.
Published: (2012-01-01) -
Effect of Different Doses of Sugammadex on Recovery and Hemodynamic Parameters in Reversing Neuromuscular Blockade in Patients Undergoing Electroconvulsive Therapy
by: Kadir ARSLAN, et al.
Published: (2024-03-01)